Complaints Allege Tempus AI Lacked Consent to Use, Share Data With Pharma Cos.. A healthcare artificial intelligence firm that sells genetic information from an acquired database holding the results of millions of screening tests faces multiple putative class action lawsuits in Chicago federal court. Genetic data resists attempts to de-identify it, plaintiffs say.
First seen on govinfosecurity.com
Jump to article: www.govinfosecurity.com/health-ai-firm-faces-lawsuits-over-dna-data-use-disclosure-a-31465
